Driving glioblastoma growth by alternative polyadenylation

被引：0
|
作者：
Ting Han
John K Kim
机构：
[1] UT Southwestern Medical Center,Department of Biochemistry
[2] Life Sciences Institute,Department of Human Genetics
[3] University of Michigan,undefined
来源：
Cell Research | 2014年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Global shortening of 3′ untranslated regions (3′ UTRs) through alternative polyadenylation is an emerging hallmark of cancer. A recent study identifies the cleavage factor Im 25 (CFIm25) as an important mediator of 3′ UTR shortening in glioblastomas and demonstrates a causal relationship between alternative polyadenylation and cancer cell proliferation.
引用
收藏
页码：1023 / 1024
页数：1
相关论文
共 50 条
  • [21] Promoters drive alternative polyadenylation
    Eytan Zlotorynski
    Nature Reviews Molecular Cell Biology, 2015, 16 : 66 - 66
  • [22] Alternative Polyadenylation in Human Diseases
    Chang, Jae-Woong
    Yeh, Hsin-Sung
    Yong, Jeongsik
    ENDOCRINOLOGY AND METABOLISM, 2017, 32 (04) : 413 - 421
  • [23] Alternative polyadenylation of mRNA precursors
    Tian, Bin
    Manley, James L.
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2017, 18 (01) : 18 - 30
  • [24] RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation
    Lin, Peng
    Chen, Wenyan
    Long, Zhilin
    Yu, Jichuan
    Yang, Jiayao
    Xia, Zhen
    Wu, Qiulian
    Min, Xinyu
    Tang, Jing
    Cui, Ya
    Liu, Fuyi
    Wang, Chun
    Zheng, Jian
    Li, Wei
    Rich, Jeremy N.
    Li, Lei
    Xie, Qi
    CELL DISCOVERY, 2024, 10 (01)
  • [25] CFIm25 links alternative polyadenylation to glioblastoma tumour suppression (vol 510, pg 412, 2014)
    Masamha, Chioniso P.
    Xia, Zheng
    Yang, Jingxuan
    Albrecht, Todd R.
    Li, Min
    Shyu, Ann-Bin
    Li, Wei
    Wagner, Eric J.
    NATURE, 2022, 612 (7940) : E11 - E11
  • [26] The growth hormone receptor as an alternative oncogenic pathway in glioblastoma
    Verreault, M.
    Ducray, F.
    Marie, Y.
    Laigle-Donadey, F.
    Rousseau, A.
    Mokhtari, K.
    Hoang-Xuan, K.
    Sanson, M.
    Delattre, J. Y.
    Idbaih, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S778 - S778
  • [27] A special focus on polyadenylation and alternative polyadenylation in neurodegenerative diseases: A systematic review
    Markid, Tarlan Yeganeh
    Pourahmadiyan, Azam
    Hamzeh, Soroosh
    Sharifi-Bonab, Mirmohsen
    Asadi, Mohamad Reza
    Jalaiei, Abbas
    Rezazadeh, Maryam
    Ghafouri-Fard, Soudeh
    JOURNAL OF NEUROCHEMISTRY, 2025, 169 (02)
  • [28] RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation
    Peng Lin
    Wenyan Chen
    Zhilin Long
    Jichuan Yu
    Jiayao Yang
    Zhen Xia
    Qiulian Wu
    Xinyu Min
    Jing Tang
    Ya Cui
    Fuyi Liu
    Chun Wang
    Jian Zheng
    Wei Li
    Jeremy N. Rich
    Lei Li
    Qi Xie
    Cell Discovery, 10
  • [29] The role of alternative polyadenylation in cancer progression
    Jain, Buddhi Prakash
    GENE REPORTS, 2018, 12 : 1 - 8
  • [30] Regulation of alternative polyadenylation by genomic imprinting
    Wood, Andrew J.
    Schulz, Reiner
    Woodfine, Kathryn
    Koltowska, Katarzyna
    Beechey, Colin V.
    Peters, Jo
    Bourc'his, Deborah
    Oakey, Rebecca J.
    GENES & DEVELOPMENT, 2008, 22 (09) : 1141 - 1146
12345